22121-58-0,
Diclofenac impurity B,
2-(2,6-Dichloroanilino)benzaldehyde,
o-(2,6-Dichloroanilino)benzaldehyde,
2-[(2,6-DICHLOROPHENYL)AMINO]BENZALDEHYDE,
2-((2,6-Dichlorophenyl)amino)benzaldehyde,
UNII-9218J5N522,
N-(2,6-Dichlorophenyl)anthranilaldehyde,
9218J5N522,
Benzaldehyde,2-[(2,6-dichlorophenyl)amino]-,
Benzaldehyde, 2-((2,6-dichlorophenyl)amino)-,
Benzaldehyde, 2-[(2,6-dichlorophenyl)amino]-,
Diclofenac Aldehyde,
Diclofenac sodium impurity B [EP],
Diclofenac potassium impurity B [EP],
Diclofenac sodium specified impurity B [EP],
Anthranilaldehyde, N-(2,6-dichlorophenyl)-,
Diclofenac potassium specified impurity B [EP],
SCHEMBL2553022,
CTK4E8677,
DTXSID90176642,
MILOIOYXRHLAAH-UHFFFAOYSA-N,
ZINC2510767,
STL452924,
AKOS027447593,
ACM22121580,
(2,6-dichloro-phenylamino)-benz-aldehyde,
FT-0666597,
2-[(2,6-Dichlorophenyl)amino]benzaldehyde (Diclofenac impurity),
2-[(2,6-Dichlorophenyl)amino]benzaldehyde, pharmaceutical impurity standard,
Diclofenac EP Impurity B,
Diclofenac Sodium impurity B,
CS-T-52646,